Basecamp Research’s Trillion Gene Atlas will bring together genomic data from millions of species to guide AI-powered design of new medicines.

Plus, news about Eledon, Sobi, Ovid and CytomX: 🗓️ Ionis updates prion disease study timelines: The California oligonucleotide powerhouse has pushed back the primary completion

Johnson & Johnson’s much-anticipated oral IL-23 drug, icotrokinra, has claimed FDA approval as Icotyde for first-line treatment of plaque psoriasis.

Always be in the clinic — those are the “ABCs” of biotech, drug development veteran Briggs Morrison tells Endpoints News. And that’s precisely where Morrison’s

Aspen Neuroscience said its experimental Parkinson’s disease treatment, made from a patient’s own cells, showed encouraging results in a small study. The clinical trial builds